Skip to content

An in-vivo investigation of the safety, efficacy of the treatments between the two spot sizes of Port-Wine Stain (PWS) by Pulsed Dye Laser (PDL) - A Prospective Side by Side Comparison Study

An in-vivo investigation of the safety, efficacy of the treatments between the two spot sizes of Port-Wine Stain (PWS) by Pulsed Dye Laser (PDL) - A Prospective Side by Side Comparison Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16009700
Enrollment
Unknown
Registered
2016-11-01
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

port-wine stain

Interventions

self-control:PDL laser treatment

Sponsors

Shanghai 9th People's Hospital Shanghai Jiaotong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 65 Years

Inclusion criteria

Inclusion criteria: 1) Aged 0-65 years; 2) healthy condition; 3) Having not accepted any treatment before participating this study; 4) Having not accepted any oral drugs which will affect blood clotting; 5) Ability and willingness to sign an inform consent form after fully understanding the therapeutic and follow-up strategies.

Exclusion criteria

Exclusion criteria: 1) Insufficient pulmonary functions and hepatorenal functions; 2) Patients with fever or WBC less than 2500 / cubic millimeter; 3) The combined use of other drugs which will affect blood clotting; 4) Serious underlying systemic disease requiring treatment until illness either completes therapy or achieves clinical stablility on therapy for at least 6 months before enrolled the study. The systemic diseases include insufficient pulmonary functions(COPD, pneumonia, pulmonary fibrosis and asthma), insufficient cardiac and hepatorenal functions, infection , hemorrhagic tendency, immunologic disease(SLE, urticaria, HIV). The termination criteria to a subject 1) Total laser treatment was not finished; 2) The subject requests to terminate treatments; 3) The subject becomes pregnant.

Design outcomes

Primary

MeasureTime frame
blanching rate;

Countries

China

Contacts

Public ContactWenxin Yu

Shanghai 9th People's Hospital Shanghai Jiaotong University, School of Medicine

860382817@qq.com+86 15618690545

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026